title: Remarkable Response to Methylprednisolone in a Multiple Myeloma Patient with Nodal Disease Refractory to High-Dose Chemotherapy.
abstract: Multiple myeloma is a disorder of malignant plasma cells, which is characterized by paraprotein production, lytic bone lesions, hypercalcemia, susceptibility to infections, and renal impairment. Here, we describe a patient with IgA myeloma with extensive nodal involvement who obtained significant benefit from high-dose methylprednisolone after failing aggressive induction chemotherapy and high-dose melphalan with autologous stem cell support.
authors.affiliation: Medicine, Roswell Park Cancer Institute.
authors.forename: Kimberly
authors.initials: K
authors.lastname: Celotto
authors.affiliation: Pathology, Roswell Park Cancer Institute.
authors.forename: Vishala
authors.initials: V
authors.lastname: Neppalli
authors.affiliation: Medicine, Roswell Park Cancer Institute.
authors.forename: Sarah
authors.initials: S
authors.lastname: Holstein
keywords: Multiple Myeloma; autologous stem cell transplantation; corticosteroid; extramedullary; nodal metastases
references.citation: Leukemia. 1995 Dec;9(12):2115-8
references.pmid: 8609725
references.citation: Br J Haematol. 1996 May;93(2):345-51
references.pmid: 8639427
references.citation: Am J Surg Pathol. 2010 Oct;34(10):1425-35
references.pmid: 20871216
references.citation: Haematologica. 2012 Nov;97(11):1761-7
references.pmid: 22689675
references.citation: Blood. 1992 Aug 15;80(4):887-90
references.pmid: 1498331
references.citation: Am J Clin Pathol. 2001 Jan;115(1):119-26
references.pmid: 11190797